BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22792)

  • 1. Evidence for inhibition of dopamine-beta-hydroxylase in vivo after sub-acute pyrazole treatment in rats.
    MacDonald E; Pispa JP
    Med Biol; 1977 Oct; 55(5):284-91. PubMed ID: 22792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of pyrazole and ethanol on norepinephrine metabolism in rat brain.
    Brown FC; Zawad J; Harralson JD
    J Pharmacol Exp Ther; 1978 Jul; 206(1):75-80. PubMed ID: 660560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of dopamine beta-hydroxylase by 4-hydroxypyrazole: ethanol-pyrazole effects on serum dopamine beta-hydroxylase in vivo.
    Harralson JD; Wolfe BI; Brown FC
    J Pharmacol Exp Ther; 1978 Jul; 206(1):69-74. PubMed ID: 660559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of monoamine neural systems in L-dihydroxyphenylalanine-stimulated activity.
    Hollister AS; Breese GR; Mueller RA
    J Pharmacol Exp Ther; 1979 Jan; 208(1):37-43. PubMed ID: 759613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological action of FD-008, a new dopamine-beta-hydroxylase inhibitor. III. Effects on endogenous biogenic amine levels in rats.
    Ishii Y; Homma M; Yoshikawa A; Umezawa H
    Arzneimittelforschung; 1975 Mar; 25(3):383-5. PubMed ID: 1174036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pyrazole treatment of physical status and brain biogenic amines in rats.
    MacDonald E
    Med Biol; 1977 Apr; 55(2):101-8. PubMed ID: 865152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of disulfiram and sodium diethyldithiocarbamate on tyrosine and dopamine-beta-hydroxylases activities in rat brain and heart.
    Szmigielski A
    Pol J Pharmacol Pharm; 1975; 27(2):153-9. PubMed ID: 239395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium: modification of behavioral activity and brain biogenic amines in developing hyperthyroid rats.
    Rastoge RB; Singhal RL
    J Pharmacol Exp Ther; 1977 Apr; 201(1):92-102. PubMed ID: 850149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The influence of mepiprazol on monoamine metabolism in the rat CNS: demonstration of reduced norepinephrine activity and simultaneously enhanced serotonin and dopamine activities (author's transl)].
    Seyfried C; Nowak H; Wolf HP
    Arzneimittelforschung; 1976; 26(6):1088-90. PubMed ID: 989382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of L-dopa on epinephrine concentration in rat brain: possible role of inhibition of norepinephrine N-methyltransferase by S-adenosylhomocysteine.
    Fuller RW; Hemrick-Luecke SK; Perry KW
    J Pharmacol Exp Ther; 1982 Oct; 223(1):84-9. PubMed ID: 7120131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-Methoxytranylcypromine, a monoamine oxidase inhibitor: effects on biogenic amines in rat brain following chronic administration.
    Sherry-McKenna RL; Baker GB; Mousseau DD; Coutts RT; Dewhurst WG
    Biol Psychiatry; 1992 May; 31(9):881-8. PubMed ID: 1353376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Various effects of monoamine oxidase inhibitors under conditions of complete monoamine oxidase inhibition on the serotonin, dopamine and noradrenaline levels in the rat brain].
    Matthies H; Popov N
    Acta Biol Med Ger; 1966; 17(4):488-97. PubMed ID: 5983631
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurochemical characteristics of cerebral catecholamine neurons during the postnatal development in the rat.
    Hedner T; Lundborg P
    Med Biol; 1981 Aug; 59(4):212-23. PubMed ID: 6803074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dopamine-beta-hydroxylase inhibitors 1,1-dimethyl-3-phenyl-2-thiourea, fusaric acid and dimethyldithiocarbamate, on the rat brain monoamine content following intraventricular injection of L-dopa.
    Vetulani J; Reichenberg K
    Biochem Pharmacol; 1973 Jun; 22(11):1263-8. PubMed ID: 4727781
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of neonatal and adult hyperthyroidism on behavior and biosynthetic capacity for norepinephrine, dopamine and 5-hydroxytryptamine in rat brain.
    Rastogi RB; Singhal RL
    J Pharmacol Exp Ther; 1976 Sep; 198(3):609-18. PubMed ID: 978462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Increase of cerebral dopamine levels by alpha-chymotrypsin in rats pretreated with oxypertine and L-dopa].
    Van den Driessche J; Le Clec'h G; Quiniou P; Linée P; Lacroix P; Patay M; Delamaire J
    C R Seances Soc Biol Fil; 1974; 168(10-11-12):1393-400. PubMed ID: 4157065
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the functional role of intraneuronal monamine oxidase.
    Clarke DE; Sampath SS
    J Pharmacol Exp Ther; 1973 Dec; 187(3):539-49. PubMed ID: 4770399
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmaceutical agents known to produce disulfiram-like reaction: effects on hepatic ethanol metabolism and brain monoamines.
    Karamanakos PN; Pappas P; Boumba VA; Thomas C; Malamas M; Vougiouklakis T; Marselos M
    Int J Toxicol; 2007; 26(5):423-32. PubMed ID: 17963129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of prolonged vasopressin administration on the level and metabolism of catecholamines in the rat brain and kidneys.
    Szmigielska H
    Acta Physiol Pol; 1976; 27(3):259-64. PubMed ID: 7918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.